Anders Karlén

发表

Toward a Benchmarking Data Set Able to Evaluate Ligand- and Structure-based Virtual Screening Using Public HTS Data

Jin Zhang, Martin Lindh, Fredrik Svensson, 2015, J. Chem. Inf. Model..

Conformational analysis of macrocycles: comparing general and specialized methods

Peter Brandt, Anders Karlén, Gustav Olanders, 2020, Journal of Computer-Aided Molecular Design.

Improved CoMFA Modeling by Optimization of Settings

Wesley Schaal, Anders Karlén, Shane D. Peterson, 2006, J. Chem. Inf. Model..

Medveten produktplacering i film : Hjärtekrossare och gravplundrare

Anders Karlén, Björn Wimnell, Fredrik Brandin, 2001 .

Docking of Macrocycles: Comparing Rigid and Flexible Docking in Glide

Wesley Schaal, Peter Brandt, Anders Karlén, 2017, J. Chem. Inf. Model..

Virtual Screening Data Fusion Using Both Structure- and Ligand-Based Methods

Fredrik Svensson, Christian Sköld, Anders Karlén, 2012, J. Chem. Inf. Model..

Focused hierarchical design of peptide libraries—follow the lead

Anders Karlén, Torbjörn Lundstedt, Daniel Muthas, 2007 .

Ligand Bias of Scoring Functions in Structure-Based Virtual Screening

Anders Karlén, Micael Jacobsson, 2006, J. Chem. Inf. Model..

Discriminant and quantitative PLS analysis of competitive CYP2C9 inhibitors versus non-inhibitors using alignment independent GRIND descriptors

Ismael Zamora, Anders Karlén, Collen M. Masimirembwa, 2002, J. Comput. Aided Mol. Des..

Structural analysis of CYP2C9 and CYP2C5 and critical assessment of molecular modelling techniques.

Anders Karlén, Florian Raubacher, Ismael Zamora, 2004 .

Identification of Plasmodium falciparum spermidine synthase active site binders through structure-based virtual screening.

Anders Karlén, Johan Schultz, Micael Jacobsson, 2008, Journal of medicinal chemistry.

Design, synthesis, and X-ray crystallographic studies of α-aryl substituted fosmidomycin analogues as inhibitors of Mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate reductoisomerase.

Martin Lindh, Anders Karlén, Mats Larhed, 2011, Journal of medicinal chemistry.

Optimization of P1-P3 groups in symmetric and asymmetric HIV-1 protease inhibitors.

Wesley Schaal, Anders Karlén, Magnus Björsne, 2003, European journal of biochemistry.

Is it possible to increase hit rates in structure-based virtual screening by pharmacophore filtering? An investigation of the advantages and pitfalls of post-filtering.

Anders Karlén, Magnus Lundborg, Daniel Muthas, 2008, Journal of molecular graphics & modelling.

Predicting the Rate of Skin Penetration Using an Aggregated Conformal Prediction Framework.

Ulf Norinder, Martin Lindh, Anders Karlén, 2017, Molecular pharmaceutics.

Hydrogen bonding descriptors in the prediction of human in vivo intestinal permeability.

Anders Karlén, Susanne Winiwarter, Hans Lennernäs, 2003, Journal of molecular graphics & modelling.

Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist.

Anders Karlén, Anders Hallberg, Y. Wan, 2004, Journal of medicinal chemistry.

Corrigendum to “Virtual screening and bioassay study of novel inhibitors for dengue virus mRNA cap (nucleoside-2′O)-methyltransferase” [Bioorg. Med. Chem. 15 (2007) 7795–7802]

Anders Karlén, Bruno Canard, Johan Åqvist, 2008 .

Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.

Anders Karlén, Gabriele Cruciani, Massimo Baroni, 2004, Journal of medicinal chemistry.

Structural analysis of CYP2C9 and CYP2C5 and an evaluation of commonly used molecular modeling techniques.

Anders Karlén, Flemming Steen Jørgensen, Florian Raubacher, 2004, Drug metabolism and disposition: the biological fate of chemicals.

Short pseudopeptides containing turn scaffolds with high AT2 receptor affinity.

Anders Karlén, Anders Hallberg, Milad Botros, 2006, Bioorganic & medicinal chemistry.

Relationships between structure and interaction kinetics for HIV-1 protease inhibitors.

Wesley Schaal, Anders Karlén, Anders Hallberg, 2002, Journal of medicinal chemistry.

Angiotensin II pseudopeptides containing 1,3,5-trisubstituted benzene scaffolds with high AT2 receptor affinity.

Christian Sköld, Anders Karlén, Anders Hallberg, 2005, Journal of medicinal chemistry.

Evaluation of the amino acid binding site of Mycobacterium tuberculosis glutamine synthetase for drug discovery.

Anders Karlén, Mats Larhed, Anneli Nordqvist, 2008, Bioorganic & medicinal chemistry.

Synthesis of a new class of druglike angiotensin II C-terminal mimics with affinity for the AT2 receptor.

Christian Sköld, Anders Karlén, Anders Hallberg, 2007, Journal of medicinal chemistry.

Beta-amino acid substitutions and structure-based CoMFA modeling of hepatitis C virus NS3 protease inhibitors.

Anders Karlén, Johanna Nurbo, Shane D Peterson, 2008, Bioorganic & medicinal chemistry.